Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19

NCT04325061 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Acute Respiratory Distress Syndrome Caused by COVID-19

Interventions

DRUG: Dexamethasone

Sponsor

Dr. Negrin University Hospital

Collaborators

[object Object]
[object Object]